SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008494
Filing Date
2022-05-09
Accepted
2022-05-09 16:11:20
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q annx-20220331.htm   iXBRL 10-Q 2346773
2 EX-10.1 annx-ex10_1.htm EX-10.1 38464
3 EX-31.1 annx-ex31_1.htm EX-31.1 20199
4 EX-31.2 annx-ex31_2.htm EX-31.2 20223
5 EX-32.1 annx-ex32_1.htm EX-32.1 19232
  Complete submission text file 0000950170-22-008494.txt   7275716

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT annx-20220331.xsd EX-101.SCH 37353
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT annx-20220331_lab.xml EX-101.LAB 345425
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT annx-20220331_def.xml EX-101.DEF 107133
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT annx-20220331_cal.xml EX-101.CAL 43498
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT annx-20220331_pre.xml EX-101.PRE 240283
52 EXTRACTED XBRL INSTANCE DOCUMENT annx-20220331_htm.xml XML 1253955
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 22905043
SIC: 2834 Pharmaceutical Preparations